Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chromatin | 12 | 2023 | 2961 | 1.160 |
Why?
|
Enhancer Elements, Genetic | 6 | 2021 | 1363 | 1.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 22 | 2024 | 8554 | 0.930 |
Why?
|
Transcription Factors | 8 | 2024 | 12130 | 0.710 |
Why?
|
Gene Expression Profiling | 14 | 2022 | 9420 | 0.640 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2021 | 339 | 0.580 |
Why?
|
Epigenesis, Genetic | 10 | 2024 | 3801 | 0.560 |
Why?
|
Paraffin Embedding | 5 | 2020 | 302 | 0.550 |
Why?
|
Tissue Fixation | 4 | 2020 | 241 | 0.530 |
Why?
|
Histone Code | 1 | 2016 | 158 | 0.490 |
Why?
|
Colorectal Neoplasms | 11 | 2021 | 6938 | 0.490 |
Why?
|
Receptors, Androgen | 6 | 2022 | 1079 | 0.480 |
Why?
|
Rectal Neoplasms | 3 | 2012 | 1157 | 0.470 |
Why?
|
Neoplastic Stem Cells | 2 | 2021 | 1351 | 0.420 |
Why?
|
Formaldehyde | 4 | 2023 | 358 | 0.400 |
Why?
|
Histones | 7 | 2022 | 2580 | 0.340 |
Why?
|
Neoplasms | 10 | 2022 | 22173 | 0.330 |
Why?
|
Prostatic Neoplasms | 6 | 2022 | 11122 | 0.330 |
Why?
|
Urinary Bladder Neoplasms | 5 | 2022 | 2223 | 0.320 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 3 | 2024 | 1136 | 0.290 |
Why?
|
Drug Resistance, Neoplasm | 8 | 2022 | 5305 | 0.280 |
Why?
|
Adenocarcinoma | 6 | 2021 | 6345 | 0.270 |
Why?
|
Proto-Oncogene Proteins | 4 | 2022 | 4514 | 0.260 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 3 | 2021 | 164 | 0.250 |
Why?
|
Chromatin Immunoprecipitation | 3 | 2016 | 855 | 0.250 |
Why?
|
Histone Demethylases | 2 | 2024 | 323 | 0.230 |
Why?
|
ras Proteins | 1 | 2009 | 1054 | 0.230 |
Why?
|
Cell Line, Tumor | 17 | 2024 | 16990 | 0.230 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2022 | 2827 | 0.230 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2023 | 423 | 0.230 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2024 | 138 | 0.220 |
Why?
|
Regulatory Sequences, Nucleic Acid | 3 | 2022 | 790 | 0.220 |
Why?
|
Lipid Peroxidation | 1 | 2004 | 271 | 0.220 |
Why?
|
Enteroendocrine Cells | 1 | 2024 | 78 | 0.220 |
Why?
|
RNA, Messenger | 3 | 2016 | 12794 | 0.220 |
Why?
|
Sequence Analysis, DNA | 5 | 2023 | 4740 | 0.210 |
Why?
|
cdc42 GTP-Binding Protein | 2 | 2017 | 187 | 0.210 |
Why?
|
Carcinoma, Transitional Cell | 2 | 2022 | 783 | 0.210 |
Why?
|
HMGN1 Protein | 2 | 2020 | 27 | 0.200 |
Why?
|
Fixatives | 2 | 2020 | 90 | 0.200 |
Why?
|
Up-Regulation | 3 | 2024 | 4125 | 0.200 |
Why?
|
Neoplasm Proteins | 2 | 2024 | 3617 | 0.190 |
Why?
|
Colonic Neoplasms | 4 | 2016 | 2539 | 0.190 |
Why?
|
Pancreatic Neoplasms | 1 | 2019 | 5368 | 0.190 |
Why?
|
Lysine | 3 | 2020 | 993 | 0.190 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2021 | 191 | 0.180 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2016 | 4576 | 0.180 |
Why?
|
SOXC Transcription Factors | 1 | 2020 | 41 | 0.180 |
Why?
|
SOX9 Transcription Factor | 1 | 2021 | 145 | 0.180 |
Why?
|
Lung Neoplasms | 6 | 2023 | 13381 | 0.180 |
Why?
|
Kaplan-Meier Estimate | 7 | 2020 | 6484 | 0.180 |
Why?
|
Chromatin Assembly and Disassembly | 2 | 2021 | 634 | 0.170 |
Why?
|
Acetylation | 5 | 2020 | 1055 | 0.170 |
Why?
|
Peptides | 1 | 2012 | 4358 | 0.170 |
Why?
|
Sciatic Neuropathy | 1 | 2000 | 76 | 0.170 |
Why?
|
Disease-Free Survival | 8 | 2016 | 6815 | 0.170 |
Why?
|
Oncogene Proteins | 2 | 2020 | 719 | 0.170 |
Why?
|
SOXB1 Transcription Factors | 1 | 2021 | 286 | 0.170 |
Why?
|
Carcinoma, Lobular | 2 | 2022 | 481 | 0.160 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2021 | 727 | 0.160 |
Why?
|
Transcription Factor AP-1 | 1 | 2020 | 321 | 0.160 |
Why?
|
Adenosine Deaminase | 1 | 2021 | 251 | 0.160 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2020 | 9280 | 0.160 |
Why?
|
Mice | 20 | 2024 | 81539 | 0.160 |
Why?
|
3' Untranslated Regions | 2 | 2021 | 519 | 0.160 |
Why?
|
Mutation | 7 | 2022 | 30053 | 0.160 |
Why?
|
Phenylurea Compounds | 1 | 2021 | 529 | 0.150 |
Why?
|
Cell Differentiation | 4 | 2024 | 11530 | 0.150 |
Why?
|
Prognosis | 18 | 2022 | 29629 | 0.150 |
Why?
|
Cell Transplantation | 1 | 2000 | 472 | 0.150 |
Why?
|
Receptors, Erythropoietin | 2 | 2008 | 144 | 0.150 |
Why?
|
Tumor Escape | 1 | 2020 | 370 | 0.150 |
Why?
|
Choline Kinase | 2 | 2007 | 5 | 0.140 |
Why?
|
Trisomy | 1 | 2018 | 260 | 0.140 |
Why?
|
Cell Lineage | 3 | 2024 | 2557 | 0.140 |
Why?
|
Antigens, Neoplasm | 2 | 2020 | 1993 | 0.140 |
Why?
|
Barrett Esophagus | 1 | 2021 | 492 | 0.140 |
Why?
|
Humans | 64 | 2024 | 761596 | 0.140 |
Why?
|
Coenzyme A Ligases | 1 | 2016 | 45 | 0.140 |
Why?
|
Animals | 26 | 2024 | 168475 | 0.140 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2020 | 1784 | 0.130 |
Why?
|
Reactive Oxygen Species | 1 | 2004 | 2139 | 0.130 |
Why?
|
Integrins | 1 | 2020 | 834 | 0.130 |
Why?
|
Mice, Inbred NOD | 2 | 2020 | 1827 | 0.130 |
Why?
|
Genome | 2 | 2022 | 1740 | 0.130 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2020 | 478 | 0.130 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2022 | 1085 | 0.130 |
Why?
|
Pyrimidines | 2 | 2021 | 3028 | 0.130 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2000 | 602 | 0.130 |
Why?
|
Nuclear Proteins | 4 | 2021 | 5799 | 0.130 |
Why?
|
Hyperalgesia | 1 | 2000 | 532 | 0.130 |
Why?
|
Histone Deacetylases | 1 | 2020 | 720 | 0.130 |
Why?
|
Signal Transduction | 9 | 2022 | 23447 | 0.130 |
Why?
|
Epigenomics | 4 | 2023 | 943 | 0.130 |
Why?
|
Sequence Analysis, RNA | 3 | 2020 | 2021 | 0.130 |
Why?
|
Prostate | 3 | 2022 | 1773 | 0.120 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1616 | 0.120 |
Why?
|
Hepatocytes | 1 | 2022 | 1233 | 0.120 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 550 | 0.120 |
Why?
|
Neuroendocrine Tumors | 1 | 2021 | 641 | 0.120 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2023 | 3639 | 0.120 |
Why?
|
Glycosyltransferases | 1 | 2014 | 116 | 0.110 |
Why?
|
Immunohistochemistry | 6 | 2021 | 11076 | 0.110 |
Why?
|
Leukemia | 1 | 2022 | 1522 | 0.110 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 2014 | 167 | 0.110 |
Why?
|
Binding Sites | 2 | 2019 | 6056 | 0.110 |
Why?
|
Oxidative Stress | 1 | 2004 | 3113 | 0.110 |
Why?
|
Telomere | 1 | 2019 | 943 | 0.110 |
Why?
|
Protein Binding | 3 | 2021 | 9353 | 0.100 |
Why?
|
Cell Nucleus | 1 | 2022 | 2910 | 0.100 |
Why?
|
Organoplatinum Compounds | 1 | 2014 | 407 | 0.100 |
Why?
|
Antineoplastic Agents | 7 | 2021 | 13642 | 0.100 |
Why?
|
Breast Neoplasms | 6 | 2022 | 21019 | 0.100 |
Why?
|
Transcription, Genetic | 4 | 2020 | 7593 | 0.100 |
Why?
|
Proto-Oncogenes | 1 | 2013 | 321 | 0.100 |
Why?
|
Homeodomain Proteins | 2 | 2019 | 2418 | 0.100 |
Why?
|
Computational Biology | 2 | 2021 | 3517 | 0.100 |
Why?
|
RNA-Binding Proteins | 1 | 2021 | 1898 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2021 | 1899 | 0.100 |
Why?
|
Polymerase Chain Reaction | 2 | 2012 | 6075 | 0.100 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2012 | 106 | 0.100 |
Why?
|
Protein Processing, Post-Translational | 1 | 2019 | 1974 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2021 | 11742 | 0.090 |
Why?
|
Apoptosis | 4 | 2020 | 9490 | 0.090 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2013 | 330 | 0.090 |
Why?
|
Transfection | 3 | 2012 | 5774 | 0.090 |
Why?
|
Esophageal Neoplasms | 1 | 2021 | 1654 | 0.090 |
Why?
|
Protein Array Analysis | 1 | 2012 | 400 | 0.090 |
Why?
|
Down Syndrome | 1 | 2018 | 901 | 0.090 |
Why?
|
Stomach Neoplasms | 2 | 2012 | 1459 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2020 | 4580 | 0.080 |
Why?
|
Dual Specificity Phosphatase 1 | 1 | 2009 | 42 | 0.080 |
Why?
|
Cell Proliferation | 6 | 2022 | 10451 | 0.080 |
Why?
|
Trans-Activators | 1 | 2019 | 2856 | 0.080 |
Why?
|
Frozen Sections | 1 | 2010 | 153 | 0.080 |
Why?
|
Embryonic Stem Cells | 1 | 2016 | 1263 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2020 | 2898 | 0.080 |
Why?
|
Endonucleases | 1 | 2012 | 371 | 0.080 |
Why?
|
DNA Methylation | 4 | 2022 | 4399 | 0.080 |
Why?
|
DNA | 1 | 2023 | 7213 | 0.080 |
Why?
|
Immunotherapy | 2 | 2021 | 4652 | 0.080 |
Why?
|
Inhibitor of Differentiation Proteins | 1 | 2008 | 17 | 0.080 |
Why?
|
Male | 25 | 2022 | 360846 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2021 | 3605 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3779 | 0.080 |
Why?
|
Stem Cells | 1 | 2021 | 3524 | 0.080 |
Why?
|
Deoxycytidine | 1 | 2012 | 877 | 0.070 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2021 | 698 | 0.070 |
Why?
|
Aged, 80 and over | 11 | 2016 | 58984 | 0.070 |
Why?
|
Hematopoietic Stem Cells | 1 | 2020 | 3397 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12059 | 0.070 |
Why?
|
Cell Survival | 4 | 2020 | 5791 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2009 | 2865 | 0.070 |
Why?
|
Nucleosomes | 2 | 2023 | 488 | 0.070 |
Why?
|
Fluorouracil | 1 | 2012 | 1642 | 0.070 |
Why?
|
Neoplasm Staging | 7 | 2020 | 11120 | 0.070 |
Why?
|
Cisplatin | 2 | 2012 | 1652 | 0.070 |
Why?
|
Clone Cells | 2 | 2020 | 1659 | 0.070 |
Why?
|
Female | 28 | 2024 | 392705 | 0.070 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2007 | 242 | 0.070 |
Why?
|
Macrophages | 1 | 2021 | 5767 | 0.070 |
Why?
|
Lipid Metabolism | 1 | 2015 | 1902 | 0.070 |
Why?
|
Neoplasm Metastasis | 5 | 2018 | 4915 | 0.060 |
Why?
|
Neoplasm Transplantation | 3 | 2020 | 2016 | 0.060 |
Why?
|
Proteins | 1 | 2020 | 6032 | 0.060 |
Why?
|
Cell Line | 5 | 2020 | 15601 | 0.060 |
Why?
|
Cell Cycle Proteins | 3 | 2022 | 3449 | 0.060 |
Why?
|
Carcinoma | 1 | 2016 | 2330 | 0.060 |
Why?
|
Organoids | 2 | 2021 | 746 | 0.060 |
Why?
|
Mice, Inbred BALB C | 3 | 2021 | 6214 | 0.060 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2021 | 1349 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2020 | 3615 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9177 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2021 | 2917 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2022 | 15936 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4878 | 0.060 |
Why?
|
Tumor Cells, Cultured | 2 | 2021 | 6131 | 0.050 |
Why?
|
RNA Interference | 3 | 2021 | 2832 | 0.050 |
Why?
|
Neoadjuvant Therapy | 2 | 2012 | 2828 | 0.050 |
Why?
|
Aged | 15 | 2018 | 169310 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2024 | 9032 | 0.050 |
Why?
|
Survival Analysis | 2 | 2016 | 10090 | 0.050 |
Why?
|
Erythropoietin | 1 | 2007 | 719 | 0.050 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2021 | 26 | 0.050 |
Why?
|
Mice, Knockout | 3 | 2024 | 14417 | 0.050 |
Why?
|
Middle Aged | 16 | 2018 | 220921 | 0.050 |
Why?
|
Mice, Inbred C57BL | 4 | 2021 | 22174 | 0.050 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 1745 | 0.050 |
Why?
|
Adult | 14 | 2022 | 221210 | 0.050 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2024 | 305 | 0.050 |
Why?
|
HT29 Cells | 1 | 2021 | 193 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2022 | 315 | 0.050 |
Why?
|
Retrospective Studies | 10 | 2022 | 80647 | 0.050 |
Why?
|
DNA-Binding Proteins | 2 | 2024 | 9610 | 0.050 |
Why?
|
Deoxycytosine Nucleotides | 1 | 2020 | 14 | 0.050 |
Why?
|
Genes, APC | 1 | 2021 | 145 | 0.050 |
Why?
|
Genes, myc | 1 | 2022 | 390 | 0.050 |
Why?
|
RNA | 2 | 2022 | 2725 | 0.050 |
Why?
|
Neurons | 1 | 2000 | 9463 | 0.050 |
Why?
|
NF-kappa B | 1 | 2009 | 2490 | 0.040 |
Why?
|
Genes, cdc | 1 | 2020 | 114 | 0.040 |
Why?
|
Tubulin | 1 | 2004 | 693 | 0.040 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2020 | 57 | 0.040 |
Why?
|
Xeroderma Pigmentosum Group D Protein | 1 | 2020 | 106 | 0.040 |
Why?
|
Metaplasia | 1 | 2021 | 322 | 0.040 |
Why?
|
Mediator Complex | 1 | 2020 | 106 | 0.040 |
Why?
|
Endogenous Retroviruses | 1 | 2021 | 111 | 0.040 |
Why?
|
Cyclin E | 1 | 2020 | 156 | 0.040 |
Why?
|
Phenylenediamines | 1 | 2020 | 88 | 0.040 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2024 | 682 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2009 | 5314 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2021 | 294 | 0.040 |
Why?
|
Base Sequence | 2 | 2021 | 12441 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2020 | 404 | 0.040 |
Why?
|
Lymphocytic choriomeningitis virus | 1 | 2020 | 177 | 0.040 |
Why?
|
Disease Progression | 4 | 2021 | 13510 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2014 | 3514 | 0.040 |
Why?
|
Ligation | 1 | 2000 | 448 | 0.040 |
Why?
|
Nitriles | 2 | 2018 | 971 | 0.040 |
Why?
|
Lymph Nodes | 3 | 2020 | 3465 | 0.040 |
Why?
|
Blotting, Western | 3 | 2013 | 5035 | 0.040 |
Why?
|
Gene Library | 1 | 2021 | 1059 | 0.040 |
Why?
|
Physical Stimulation | 1 | 2000 | 517 | 0.040 |
Why?
|
Acrylamides | 1 | 2020 | 260 | 0.040 |
Why?
|
Chemotaxis | 1 | 2021 | 598 | 0.040 |
Why?
|
Introns | 1 | 2021 | 981 | 0.040 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2021 | 504 | 0.040 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2020 | 332 | 0.040 |
Why?
|
Azepines | 1 | 2020 | 329 | 0.040 |
Why?
|
Immune Evasion | 1 | 2021 | 363 | 0.040 |
Why?
|
Phenotype | 3 | 2021 | 16592 | 0.040 |
Why?
|
Tamoxifen | 1 | 2022 | 965 | 0.040 |
Why?
|
Treatment Outcome | 7 | 2015 | 64685 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2022 | 858 | 0.040 |
Why?
|
Drug Synergism | 1 | 2021 | 1757 | 0.040 |
Why?
|
Interferons | 1 | 2021 | 706 | 0.040 |
Why?
|
Substrate Specificity | 1 | 2021 | 1791 | 0.040 |
Why?
|
Ganglia, Spinal | 1 | 2000 | 526 | 0.040 |
Why?
|
Chemokines | 1 | 2021 | 959 | 0.040 |
Why?
|
Genetic Testing | 1 | 2010 | 3537 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2020 | 561 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2022 | 988 | 0.030 |
Why?
|
Oncogenes | 1 | 2022 | 1222 | 0.030 |
Why?
|
Phenylthiohydantoin | 1 | 2018 | 205 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2012 | 4317 | 0.030 |
Why?
|
Antioxidants | 1 | 2004 | 1668 | 0.030 |
Why?
|
Workflow | 1 | 2021 | 851 | 0.030 |
Why?
|
Cold Temperature | 1 | 2000 | 785 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2022 | 1756 | 0.030 |
Why?
|
DNA Helicases | 1 | 2021 | 851 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2020 | 1085 | 0.030 |
Why?
|
Gene Dosage | 1 | 2020 | 1218 | 0.030 |
Why?
|
Data Mining | 1 | 2021 | 551 | 0.030 |
Why?
|
1-Acylglycerol-3-Phosphate O-Acyltransferase | 1 | 2015 | 9 | 0.030 |
Why?
|
Muscles | 1 | 2020 | 1576 | 0.030 |
Why?
|
Immunoenzyme Techniques | 2 | 2008 | 1704 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1892 | 0.030 |
Why?
|
Amino Acids | 1 | 2021 | 1718 | 0.030 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2020 | 774 | 0.030 |
Why?
|
Multiprotein Complexes | 1 | 2021 | 1120 | 0.030 |
Why?
|
Regression Analysis | 2 | 2015 | 6345 | 0.030 |
Why?
|
Cell Membrane | 1 | 2004 | 3687 | 0.030 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2015 | 85 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1092 | 0.030 |
Why?
|
Survival Rate | 3 | 2020 | 12723 | 0.030 |
Why?
|
Triazoles | 1 | 2020 | 903 | 0.030 |
Why?
|
Antigens | 1 | 2020 | 1443 | 0.030 |
Why?
|
DNA Damage | 1 | 2004 | 2449 | 0.030 |
Why?
|
Mitochondria | 2 | 2005 | 3624 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 2023 | 4615 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2022 | 2209 | 0.030 |
Why?
|
Energy Metabolism | 1 | 2005 | 2882 | 0.030 |
Why?
|
rab3 GTP-Binding Proteins | 1 | 2013 | 29 | 0.030 |
Why?
|
Hot Temperature | 1 | 2000 | 1440 | 0.030 |
Why?
|
Calcium Channels | 1 | 2017 | 620 | 0.030 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2014 | 276 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2020 | 1964 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2000 | 3810 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 4111 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 1 | 2017 | 1062 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 2020 | 0.030 |
Why?
|
Benzamides | 1 | 2018 | 1371 | 0.030 |
Why?
|
Young Adult | 3 | 2016 | 59260 | 0.030 |
Why?
|
Immunoblotting | 1 | 2015 | 1646 | 0.030 |
Why?
|
Gene Deletion | 1 | 2020 | 2665 | 0.020 |
Why?
|
Recurrence | 2 | 2015 | 8466 | 0.020 |
Why?
|
E-Selectin | 1 | 2014 | 576 | 0.020 |
Why?
|
Behavior, Animal | 1 | 2000 | 1878 | 0.020 |
Why?
|
Apolipoproteins | 1 | 2014 | 326 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2020 | 1609 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2020 | 2201 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2024 | 4415 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4281 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2022 | 2986 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 3 | 2021 | 17904 | 0.020 |
Why?
|
Lymphatic Metastasis | 2 | 2008 | 2915 | 0.020 |
Why?
|
Mice, Nude | 2 | 2007 | 3614 | 0.020 |
Why?
|
Etoposide | 1 | 2012 | 634 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2014 | 675 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2811 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18255 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2451 | 0.020 |
Why?
|
Pain Measurement | 1 | 2000 | 3551 | 0.020 |
Why?
|
Gene Frequency | 1 | 2016 | 3606 | 0.020 |
Why?
|
Vincristine | 1 | 2012 | 1036 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2020 | 5485 | 0.020 |
Why?
|
Graft Survival | 1 | 2000 | 3820 | 0.020 |
Why?
|
Chromones | 1 | 2009 | 148 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2013 | 571 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9542 | 0.020 |
Why?
|
Carboplatin | 1 | 2012 | 794 | 0.020 |
Why?
|
Models, Genetic | 1 | 2018 | 3442 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2015 | 2707 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2017 | 1745 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2010 | 370 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2015 | 12463 | 0.020 |
Why?
|
Neoplastic Processes | 1 | 2007 | 35 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2009 | 2457 | 0.020 |
Why?
|
Genome, Human | 1 | 2021 | 4425 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3878 | 0.020 |
Why?
|
Gene Expression | 1 | 2020 | 7581 | 0.020 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 441 | 0.020 |
Why?
|
Cadherins | 1 | 2012 | 903 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2020 | 4937 | 0.020 |
Why?
|
Biological Assay | 1 | 2010 | 626 | 0.020 |
Why?
|
beta Catenin | 1 | 2012 | 1040 | 0.020 |
Why?
|
Sulfones | 1 | 2009 | 448 | 0.020 |
Why?
|
Reference Standards | 1 | 2010 | 1003 | 0.020 |
Why?
|
Morpholines | 1 | 2009 | 581 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2017 | 20100 | 0.020 |
Why?
|
Gastric Mucosa | 1 | 2008 | 604 | 0.020 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2005 | 78 | 0.020 |
Why?
|
Time Factors | 3 | 2015 | 39969 | 0.020 |
Why?
|
Chaperonin 60 | 1 | 2005 | 97 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2018 | 4758 | 0.020 |
Why?
|
Proton-Translocating ATPases | 1 | 2005 | 112 | 0.020 |
Why?
|
Doxorubicin | 1 | 2012 | 2224 | 0.020 |
Why?
|
Colon | 1 | 2013 | 1792 | 0.020 |
Why?
|
Boronic Acids | 1 | 2009 | 915 | 0.020 |
Why?
|
Kidney | 1 | 2020 | 7048 | 0.020 |
Why?
|
Cell Movement | 1 | 2017 | 5205 | 0.020 |
Why?
|
DNA Repair | 1 | 2014 | 2046 | 0.020 |
Why?
|
Pain | 1 | 2000 | 5073 | 0.020 |
Why?
|
Liver | 1 | 2020 | 7528 | 0.010 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2005 | 411 | 0.010 |
Why?
|
Models, Biological | 1 | 2020 | 9469 | 0.010 |
Why?
|
Rats | 1 | 2000 | 23741 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2014 | 4243 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2020 | 7859 | 0.010 |
Why?
|
Pyruvate Kinase | 1 | 2005 | 189 | 0.010 |
Why?
|
Pyrazines | 1 | 2009 | 1202 | 0.010 |
Why?
|
Clinical Trials as Topic | 2 | 2012 | 8002 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2010 | 1742 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2020 | 10194 | 0.010 |
Why?
|
Drugs, Investigational | 1 | 2004 | 212 | 0.010 |
Why?
|
Gene Silencing | 1 | 2008 | 1509 | 0.010 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2006 | 610 | 0.010 |
Why?
|
Glycolysis | 1 | 2005 | 835 | 0.010 |
Why?
|
Down-Regulation | 1 | 2008 | 2919 | 0.010 |
Why?
|
Early Diagnosis | 1 | 2006 | 1186 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2008 | 3597 | 0.010 |
Why?
|
Genotype | 1 | 2014 | 12990 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39106 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8321 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2004 | 3597 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2007 | 6534 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2008 | 5790 | 0.010 |
Why?
|
Forecasting | 1 | 2006 | 2928 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8527 | 0.010 |
Why?
|
Breast | 1 | 2005 | 1967 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2015 | 12690 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 22176 | 0.010 |
Why?
|
Proteome | 1 | 2005 | 1862 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 10212 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2004 | 2425 | 0.010 |
Why?
|
Sex Factors | 1 | 2008 | 10554 | 0.010 |
Why?
|
Child | 1 | 2022 | 80158 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2010 | 15266 | 0.010 |
Why?
|
Proteomics | 1 | 2006 | 3848 | 0.010 |
Why?
|
Decision Making | 1 | 2006 | 3929 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 14665 | 0.010 |
Why?
|
Risk Factors | 2 | 2010 | 74213 | 0.010 |
Why?
|
Prospective Studies | 1 | 2014 | 54423 | 0.010 |
Why?
|
Genomics | 1 | 2006 | 5821 | 0.010 |
Why?
|
Risk Assessment | 1 | 2010 | 23996 | 0.000 |
Why?
|